Terapias Avanzadas para Enfermedades Hepáticas Raras
AAV4Cancer
![Foto de Terapias Avanzadas para Enfermedades Hepáticas Raras](/img/uploaded/f0cba6fe852c1cc84e13dd6b700bdc8f.jpg)
![Foto de Washington University in St. Louis School of Medicine](/img/noimage_org.png)
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (2)
2014
-
CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma
Oncotarget, Vol. 5, Núm. 16, pp. 6854-6866
2012
-
ERK1/2 regulation of CD44 modulates oral cancer aggressiveness
Cancer Research, Vol. 72, Núm. 1, pp. 365-374